| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |